Items

I. Andreadou, P. Adamovski, M. Bartekova, C. Beauloye, L. Bertrand, D. Biedermann, V. Borutaite, H. Erik Botker, M. Dambrova, S. Chlopicki, Y. Devaux, S. Davidson, F. Di Lisa, D. Djuric, D. Erlinge, I. Falcao-Pires, E. Galatou, D. Garcia-Dorado, A. Garcia-Sosa, H. Girao, M. Gyongyosi, Z. Giricz, D. Healy, G. Heusch, V. Jakovljevic, J. Jovanic, F. Kolar, B. Kwak, P. Leszek, E. Liepnish, S. Longnus, J. Marinovic, D. Muntean, L. Nežić, M. Ovize, P. Paglliaro, C. Pedrosa da Costa Gomes, J. Pernow, A. Persidis, S. Pischke, B. Podesser, F. Prunier, T. Ravingerova, M. Ruiz-Meana, R. Schulz, A. Scridon, K. Slagsvold, J. Lonborg, B. Turan, N. van Royen, M. Vendelin, S. Walsh, D. Yellon, N. Zidar, C. Zuurbier, P. Ferdinandy, D. Hausenloy, Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225, Conditioning medicine, Vol. 1, No. 3, pp. 116 - 123, Apr, 2018

Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225 (2018-04)